Our findings suggested that hsa-miR-329-3p reduced the immunosuppression in HCC cells and promotes its response toward T cell-induced cytotoxic effect by inhibiting PD-L1 expression in HCC through targeting KDM1A mRNA and indirectly reducing MEF2D demethylation. This evidence concerns the gene KDM1A and hepatocellular carcinoma.